91AV

Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information.

Patents and Freedom to Operate for Chemists and Biologists

23 July 2025 13:00 - 24 July 2025 16:00, United Kingdom


Introduction
Freedom to Operate (FTO), or freedom to practise, is the ability to use a method or process, launch a product or offer a service without infringing a third party patent.  Delegates on this 6 hour online course, presented live over two days, will learn how to identify and navigate third party 'blocking' patents in the chemical and biological industries such as Life Sciences and Pharma.

Topics to be covered are:

DAY 1 - 3 Hours​
  • IP Rights in the Chemical and Biological Industries (e.g. patents and trade secrets)
  • Protecting chemical and biological inventions (e.g. small molecules, processes, antibodies)
  • The European Patent with Unitary Effect ('Unitary Patent')
  • The Patent Lifecycle (e.g. from priority filing, national/PCT applications, to patent grant)
  • Patent Term and Patent Term Extension (e.g, Supplementary Protection Certificates)
  • Regulatory Data Protection
  • How to read a Patent and Interpret Claims
  • Ownership of IP rights

DAY 2 - 3 Hours​
  • Patent & Database Searching: (e,g. for FTO, regulatory data, and patent status)
  • Patent Infringement and exceptions to infringement (e.g. Bolar provisions)
  • Enforcement of Patents in the UK and before the Unitary Patent Court
  • Challenging Patents (e.g. in the UK, Europe or USA)
  • Freedom to Operate - how to identify and deal with troublesome Third Party Patents
  • Case Studies (e.g. CRISPR)
  • FTO Group Exercises
Speakers
Venue

United Kingdom

Organised by
Assimilate IP
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*